Nitration of tau protein is linked to neurodegeneration in tauopathies

American Journal of Pathology

Volumn 163, Issue 3, 2003, Pages 1021-1031

  Horiguchi, Takashi ^a   Uryu, Kunihiro ^a   Giasson, Benoit I ^a   Ischiropoulos, Harry ^b   LightFoot, Richard ^b   Bellmann, Christine ^c   Richter Landsberg, Christiane ^c   Lee, Virginia M Y ^a   Trojanowski, John Q ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF OLDENBURG   (Germany)

^d HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TAU PROTEIN; THIOFLAVINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DOWN SYNDROME; FEMALE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEOCORTEX; NITRATION; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN MODIFICATION;

EID: 0042926482     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63462-1     Document Type: Article

References (57)

1. Markesbery WR, Carney JM: Oxidative alterations in Alzheimer's disease. Brain Pathol 1999, 9:133-146
2. Takeda A, Smith MA, Avila J, Nunomura A, Siedlak SL, Zhu X, Perry G, Sayre LM: In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem 2000, 75:1234-1241
3. Pratico D, Lee VMY, Trojanowski JQ, Rokach J, FitzGerald GA: Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. EMBO J 1998, 12:1777-1783
4. Smith MA, Richey Harris PL, Sayre LM, Beckman JS, Perry G: Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 1997, 17:2653-2657
5. Hensley K, Maidt ML, Yu Z, Sang H, Markesbery WR, Floyd RA: Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. J Neurosci 1998, 18:8126-8132
6. Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B: An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J Neurochem 1997, 68:2061-2069
7. Jovanovic SV, Clements D, MacLeod K: Biomarkers of oxidative stress are significantly elevated in Down syndrome. Free Radic Biol Med 1998, 25:1044-1048
8. Hayn M, Kremser K, Singewald N, Cairns N, Nemethova M, Lubec B, Lubec G: Evidence against the involvement of reactive oxygen species in the pathogenesis of neuronal death in Down's syndrome and Alzheimer's disease. Life Sci 1996, 59:537-544
9. Cookson MR, Shaw PJ: Oxidative stress and motor neurone disease. Brain Pathol 1999, 9:165-186
10. Browne SE, Ferrante RJ, Beal MF: Oxidative stress in Huntington's disease. Brain Pathol 1999, 9:147-163
11. Jenner P, Olanow CW: Understanding cell death in Parkinson's disease. Ann Neurol 1998, 44:S72-S84
12. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VMY: Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions. Science 2000, 290:985-989
13. O'Donnell VB, Eiserich JP, Chumley PH, Jablonsky MJ, Krishna NR, Kirk M, Barnes S, Darley-Usmar VM, Freeman BA: Nitration of unsaturated fatty acids by nitric oxide-derived reactive nitrogen species peroxynitrite, nitrous acid, nitrogen dioxide, and nitronium ion. Chem Res Toxicol 1999, 12:83-92
14. White CR, Patel RP, Darley-Usmar V: Nitric oxide donor generation from reactions of peroxynitrite. Methods Enzymol 1999, 301:288-298
15. Good PF, Werner P, Hsu A, Olanow CW, Perl DP: Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol 1996, 149:21-28
16. Good PF, Hsu A, Werner P, Perl DP, Olanow CW: Protein nitration in Parkinson's disease. J Neuropathol Exp Neurol 1998, 57:338-342
17. Gomez-Tortosa E, Gonzalo I, Newell K, Yebenes G, Vonsattel P, Hyman BT: Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration Acta Neuropathol (Berl) 2002, 103: 495-500
18. Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VMY, Trojanowski JQ: Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol 2000, 157:1439-1445
19. Cleveland DW, Hwo SY, Kirschner MW: Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 1977, 116:207-225
20. Binder LI, Frankfurter A, Rebhun LI: The distribution of tau in the mammalian central nervous system. J Cell Biol 1985, 101:1371-1378
21. Couchie D, Mavilia C, Georgieff IS, Liem RK, Shelanski ML, Nunez J: Primary structure of high molecular weight tau present in the peripheral nervous system. Proc Natl Acad Sci USA 1992, 89:4378-4381
22. Drechsel DN, Hyman AA, Cobb MH, Kirschner MW: Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 1992, 3:1141-1154
23. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW: A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 1975, 72:1858-1862
24. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD: Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998, 43:815-825
25. Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, Petersen RC, Stevens M, de Graaff E, Wauters E, van Baren J, Hillebrand M, Joosse M, Kwon JM, Nowotny P, Heutink P: Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705
26. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A, Morris JC, Wilhelmsen KC, Schellenberg GD, Trojanowski JQ, Lee VMY: Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 1998, 282:1914-1917
27. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VMY: Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 1993, 10:1089-1099
28. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA: Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease. Neuron 1989, 3:519-526
29. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998, 95:7737-7741
30. Lee VMY, Balin BJ, Otvos Jr L, Trojanowski JQ: A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 1991, 251:675-678
31. Forman MS, Lee VMY, Trojanowski JQ: New insights into genetic and molecular mechanisms of brain degeneration in tauopathies. J Chem Neuroanat 2000, 20:225-244
32. Souza JM, Giasson BI, Chen Q, Lee VMY, Ischiropoulos H: Dityrosine cross-linking promotes formation of stable α-synuclein polymers: implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem 2000, 275:18344-18349
33. Norris EH, Giasson BI, Ischiropoulos H, Lee VMY: Effects of oxidative and nitrative challenges on α-synuclein fibrillogenesis involve distinct mechanisms of protein modifications J Biol Chem 2003, 278:27230-27240
34. Giasson BI, Murray IV, Trojanowski JQ, Lee VMY: A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly. J Biol Chem 2001, 276:2380-2386
35. Mural H, Pierce JE, Raghupathi R, Smith DH, Saatman KE, Trojanowski JQ, Lee VMY, Loring JF, Eckman C, Younkin S, McIntosh TK: Twofold overexpression of human β-amyloid precursor proteins in transgenic mice does not affect the neuromotor, cognitive, or neurodegenerative sequelae following experimental brain injury. J Comp Neurol 1998, 392:428-438
36. Nakagawa Y, Nakamura M, McIntosh TK, Rodriguez A, Berlin JA, Smith DH, Saatman KE, Raghupathi R, Clemens J, Saido TC, Schmidt ML: Lee VMY, Trojanowski JQ: Traumatic brain injury in young, amyloid-β peptide overexpressing transgenic mice induces marked ipsilateral hippocampal atrophy and diminished Aβ deposition during aging. J Comp Neurol 1999, 411:390-398
37. Galvin JE, Uryu K, Lee VMY, Trojanowski JQ: Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains α-, β-, and γ-synuclein. Proc Natl Acad Sci USA 1999, 96:13450-13455
38. Smith RM, Jarret L: Electron microscopc immunocytochemical approaches to the localization of ligands, receptors, transducers, and transporters. Handbook of Endocrine Research Techniques. Edited by de Pablo F. San Diego, Academic Press, 1993, pp 227-264
39. Richter-Landsberg C, Heinrich M: OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res 1996, 45:161-173
40. Vogelsberg-Ragaglia V, Bruce J, Richter-Landsberg C, Zhang B, Hong M, Trojanowski JQ, Lee VMY: Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells. Mol Biol Cell 2000, 11:4093-4104
41. Neuhoff V, Philipp K, Zimmer HG, Mesecke S: A simple, versatile, sensitive and volume-independent method for quantitative protein determination which is independent of other external influences. Hoppe Seylers Z Physiol Chem 1979, 360:1657-1670
42. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991, 82:239-259
43. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 1991, 41:479-486
44. Sun A, Nguyen XV, Bing G: Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J Histochem Cytochem 2002, 50:463-472
45. Lindwall G, Cole RD: Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem 1984, 259:5301-5305
46. Gustke N, Steiner B, Mandelkow EM, Biernat J, Meyer HE, Goedert M, Mandelkow E: The Alzheimer-like phosphorylation of tau protein reduces microtubule binding and involves Ser-Pro and Thr-Pro motifs. FEBS Lett 1992, 307:199-205
47. Sasaki N, Fukatsu R, Tsuzuki K, Hayashi Y, Yoshida T, Fujii N, Koike T, Wakayama I, Yanagihara R, Garruto R, Amano N, Makita Z: Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases. Am J Pathol 1998, 153:1149-1155
48. Nunomura A, Perry G, Pappolla MA, Wade R, Hirai K, Chiba S, Smith MA: RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999, 19:1959-1964
49. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G: Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 2000, 1502: 139-144
50. Perry G, Nunomura A, Hirai K, Takeda A, Aliev G, Smith MA: Oxidative damage in Alzheimer's disease: the metabolic dimension. Int J Dev Neurosci 2000, 18:417-421
51. Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, Sayre LM, Monnier VM, Perry G: Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 1994, 91:5710-5714
52. Ledesma MD, Bonay P, Colaco C, Avila J: Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 1994, 269:21614-21619
53. Ginsberg SD, Hemby SE, Lee VMY, Eberwine JH, Trojanowski JQ: Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 2000, 48:77-87
54. Ishihara T, Hong M, Zhang B, Nakagawa Y, Lee MK, Trojanowski JQ, Lee VMY: Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform. Neuron 1999, 24:751-762
55. Kosik KS, Orecchio LD, Binder L, Trojanowski JQ, Lee VMY, Lee G: Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1988, 1:817-825
56. Mawal-Dewan M, Henley J, Van de Voorde A, Trojanowski JQ, Lee VMY: The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases. J Biol Chem 1994, 269: 30981-30987
57. PHF proteins display the same biochemical properties as normal tau. J Biol Chem 1992, 267:564-569